Myelodysplastic Syndrome and Acute Myeloid Leukemia Associated With PARP Inhibitors (MyeloRIB)

Condition:   Cancer Intervention:   Drug: PARP Inhibitors Sponsor:   University Hospital, Caen Active, not recruiting

Source: ClinicalTrials.gov - March 30, 2020 Category: Research Source Type: clinical trials